What We Heard at ABFO 2026: AI Is the Priority — and Many Don't Know Where to Start
Takeaways from Condor's panel at ABFO 2026 with EY, BridgeBio and Addition Therapeutics.

Takeaways from Condor's panel at ABFO 2026 with EY, BridgeBio and Addition Therapeutics. The discussion covered where clinical finance teams should begin with AI.



